UNSPSC 51303616: Undecylenic acid/zinc undecylenate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE102. This VA Drug Class (DE102) classifies this compound as belonging to the group ANTIFUNGAL, TOPICAL.

UNSPSC 51303616 Undecylenic acid/zinc undecylenate is a Commodity code that maps poorly to the recent state and local opportunities posted under it. The code's nominal scope—pharmaceutical or topical antimicrobial compounds—does not align with the solicitations appearing in the category. The City of Austin's IFB 2200 CSH1061 solicits liquid aluminum sulfate (alum) for wastewater treatment phosphorus removal, and the City of Tampa's ITB 25-P-00157 solicits medical aid supplies including antiseptic sprays, hydrogen peroxide, bandages, and first aid kits for the Fire Rescue Department. While Tampa's antiseptic spray and hydrogen peroxide offerings touch on antimicrobial chemistry, neither opportunity reflects the Commodity code's specific active ingredients or intended use in dermatological or antifungal applications. The code shows little relevant recent activity aligned with its stated scope.

The two opportunities span different issuing bodies—a city water utility and a municipal fire department—and different geographies (Texas and Florida), but neither represents a meaningful signal for pursuit under this UNSPSC designation. The Austin procurement, due August 25, 2026, emphasizes local and small business preferences (5% and 3% bid discounts on awards under $50 million), NSF approval, AWWA B403 compliance, and a 12-month firm pricing term with up to 25% annual adjustment. The Tampa procurement, originally due April 9, 2025, targets SLBEs and U-WMBEs with 5% bid discounts capped at $10,000 to $20,000. Neither solicitation reflects demand for the active pharmaceutical ingredients the Commodity code nominally covers. Business development professionals should verify the correct UNSPSC designation if pursuing antimicrobial pharmaceutical supply opportunities in state and local procurement.